Price Chart
Key Statistics
Previous Close
$26.86Day Range
52-Week Range
Avg Volume
4.7KDividend Yield
—Expense Ratio
0.79%AUM
$9.4MShares Outstanding
243.5KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Country Allocation
| Country | Weight % |
|---|---|
| United States | 92.61% |
| Other | 3.77% |
| Bermuda | 1.05% |
| Switzerland | 0.36% |
| United Kingdom | 0.35% |
| Canada | 0.34% |
| Singapore | 0.32% |
| Ireland | 0.17% |
| Panama | 0.16% |
| Monaco | 0.15% |
| Israel | 0.13% |
| Bahamas | 0.11% |
| Cayman Islands | 0.10% |
| Costa Rica | 0.09% |
| Germany | 0.09% |
| Greece | 0.09% |
| Luxembourg | 0.06% |
| China | 0.05% |
Fund Information
- Issuer
- Innovator
- Inception Date
- Feb 23, 2026
- Exchange
- NYSE_ARCA
- Description
- The Innovator U.S. Small Cap Managed 10 Buffer ETF is actively managed by Parametric and designed to provide U.S. small-cap equity exposure with reduced volatility, while seeking to protect the fund against 10%-14% of reference asset losses.
The Innovator U.S. Small Cap Managed 10 Buffer ETF (KBFR) is an exchange-traded fund issued by Innovator that launched on Feb 23, 2026. It currently manages $9.4M in assets under management. The fund charges an expense ratio of 0.79%. The fund holds 843 securities in its portfolio.
Top 10 holdings represent 6.4% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | — | US BANK MMDA - USBGFS 9 09/01/2037 | 3.22% | 302,654 | $303K |
| 2 | — | IWM 03/31/2027 247 P | 0.59% | 82 | $55K |
| 3 | — | IWM 12/31/2026 260 P | 0.57% | 82 | $53K |
| 4 | FROG | JFrog Ltd | 0.29% | 350 | $28K |
| 5 | AVT | Avnet Inc | 0.29% | 298 | $27K |
| 6 | — | IWM 09/30/2026 260 P | 0.28% | 81 | $27K |
| 7 | VSH | Vishay Intertechnology Inc | 0.28% | 441 | $26K |
| 8 | TGTX | TG Therapeutics Inc | 0.28% | 490 | $26K |
| 9 | APGE | Apogee Therapeutics Inc | 0.28% | 196 | $26K |
| 10 | PTGX | Protagonist Therapeutics Inc | 0.27% | 210 | $26K |
| 11 | SYRE | Spyre Therapeutics Inc | 0.26% | 280 | $25K |
| 12 | PTCT | PTC Therapeutics Inc | 0.26% | 288 | $24K |
| 13 | GTES | Gates Industrial Corp PLC | 0.26% | 833 | $24K |
| 14 | NPO | Enpro Inc | 0.25% | 63 | $24K |
| 15 | MYRG | MYR Group Inc | 0.25% | 49 | $24K |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | +0.79% | |
| 1W | +3.02% | |
| 1M | +5.08% | |
| 3M | +12.13% | |
| 6M | +9.38% | |
| YTD | +9.38% | |
| 1Y | +9.38% | |
| 3Y | +9.38% | |
| 5Y | +9.38% |
Moving Averages
$26.29
Above 20-Day MA$25.84
Above 50-Day MA$25.37
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$27.31
Current Price
$27.07
52-Week Low
$24.11
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
No category data available for comparison.
Compare with Another ETF
Search for an ETF to compare with KBFR:
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.